Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT02579811
Title Axitinib Given on an Individualized Schedule for Metastatic Renal Cell Cancer
Recruitment Completed
Gender both
Phase Phase II
Variant Requirements No
Sponsors Case Comprehensive Cancer Center
Indications
Therapies
Age Groups: adult
Covered Countries USA


No variant requirements are available.